
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.450 | 0.450 | 0.000 |
Shares | 99.550 | 99.550 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.490 | 18.107 |
Price to Book | 2.728 | 3.018 |
Price to Sales | 2.110 | 2.223 |
Price to Cash Flow | 10.808 | 12.107 |
Dividend Yield | 1.798 | 2.045 |
5 Years Earnings Growth | 15.765 | 10.414 |
Name | Net % | Category Average |
---|---|---|
Technology | 28.240 | 23.557 |
Financial Services | 17.450 | 16.893 |
Healthcare | 13.060 | 13.093 |
Communication Services | 9.880 | 7.900 |
Industrials | 8.940 | 11.625 |
Consumer Cyclical | 8.530 | 10.567 |
Consumer Defensive | 6.070 | 7.484 |
Real Estate | 4.210 | 2.761 |
Basic Materials | 2.980 | 3.981 |
Utilities | 0.640 | 2.552 |
Number of long holdings: 175
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Apple | US0378331005 | 6.91 | 209.28 | +0.44% | |
Microsoft | US5949181045 | 5.57 | 391.85 | +1.17% | |
NVIDIA | US67066G1040 | 5.48 | 111.01 | +4.30% | |
Mastercard | US57636Q1040 | 2.44 | 533.48 | -0.37% | |
Alphabet A | US02079K3059 | 2.06 | 161.96 | +1.68% | |
Alphabet C | US02079K1079 | 1.88 | 163.85 | +1.47% | |
Eli Lilly | US5324571083 | 1.67 | 884.54 | +2.89% | |
Linde PLC | IE000S9YS762 | 1.54 | 391.600 | -1.06% | |
Novartis | CH0012005267 | 1.51 | 92.54 | +0.59% | |
TE Connectivity | IE000IVNQZ81 | 1.46 | 144.37 | +0.59% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0461105529 | 2.59B | -9.32 | 8.05 | 10.46 | ||
LU2403432821 | 2.59B | -5.68 | - | - | ||
LU1819524072 | 424.97M | 0.30 | 1.80 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review